SANDUPHQ · SANDU PHARMACEUTICALS LTD. · Financials
Market Cap
362.29M INR
Shares
9.66M
Volume · Nov 13
591
Avg daily vol (3M)
2886
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
699.35M
+4.1%
FY2026
Net Income
17.66M
+14%
FY2026
Operating Cash Flow
61.16M
+543.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 696.24M | 699.35M | 671.92M |
| INR | 6.63M | 6.77M | 6.71M |
| INR | 1.16M | 1.12M | 1.03M |
| INR | 26.77M | 26.55M | 21.56M |
| INR | 9.06M | 8.89M | 6.07M |
| INR | 17.71M | 17.66M | 15.49M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 15.46M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.